Elbaz J - Search Results

1

An empirical analysis of overall survival in drug approvals by the US FDA (2006-2023).

Elbaz J, Haslam A, Prasad V. Elbaz J, et al. Cancer Med. 2024 Apr;13(8):e7190. doi: 10.1002/cam4.7190. Cancer Med. 2024. PMID: 38659418 Free PMC article.

2

Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial.

Kim MH, Elbaz J, Jilg N, Gustafson JL, Xu M, Hatipoglu D, Nohelty E, Kim AY, Chung RT. Kim MH, et al. Among authors: elbaz j. Front Med (Lausanne). 2023 Feb 24;10:1095828. doi: 10.3389/fmed.2023.1095828. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36910479 Free PMC article.

3

Parallel engineering of environmental bacteria and performance over years under jungle-simulated conditions.

Chemla Y, Dorfan Y, Yannai A, Meng D, Cao P, Glaven S, Gordon DB, Elbaz J, Voigt CA. Chemla Y, et al. Among authors: elbaz j. PLoS One. 2022 Dec 14;17(12):e0278471. doi: 10.1371/journal.pone.0278471. eCollection 2022. PLoS One. 2022. PMID: 36516154 Free PMC article.

4

Highly efficient reprogrammable mouse lines with integrated reporters to track the route to pluripotency.

Elbaz J, Puri MC, Faiz M, Bang KWA, Nguyen L, Makovoz B, Gertsenstein M, Hussein SMI, Zandstra PW, Briollais L, Shakiba N, Nagy A. Elbaz J, et al. Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2207824119. doi: 10.1073/pnas.2207824119. Epub 2022 Dec 1. Proc Natl Acad Sci U S A. 2022. PMID: 36454756 Free PMC article.

5

Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT).

Addeo A, Hochmair M, Janzic U, Dudnik E, Charpidou A, Płużański A, Ciuleanu T, Donev IS, Elbaz J, Aarøe J, Ott R, Peled N. Addeo A, et al. Among authors: elbaz j. Ther Adv Med Oncol. 2021 Nov 29;13:17588359211059874. doi: 10.1177/17588359211059874. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 35173817 Free PMC article.

6

Genetically Encoding Ultrastable Virus-like Particles Encapsulating Functional DNA Nanostructures in Living Bacteria.

Zilberzwige-Tal S, Alon DM, Gazit D, Zachariah S, Hollander A, Gazit E, Elbaz J. Zilberzwige-Tal S, et al. Among authors: elbaz j. ACS Synth Biol. 2021 Aug 20;10(8):1798-1807. doi: 10.1021/acssynbio.0c00586. Epub 2021 Jun 2. ACS Synth Biol. 2021. PMID: 34077194

7

Assessing the Risk of HIV and Hepatitis C among Internally Displaced Persons in Georgia.

Elbaz J. Elbaz J. Ann Glob Health. 2020 Jun 24;86(1):66. doi: 10.5334/aogh.2671. Ann Glob Health. 2020. PMID: 32607311 Free PMC article. Review.

8

Engineering a DNAzyme-Based Operon System for the Production of DNA Nanoscaffolds in Living Bacteria.

Alon DM, Voigt CA, Elbaz J. Alon DM, et al. Among authors: elbaz j. ACS Synth Biol. 2020 Feb 21;9(2):236-240. doi: 10.1021/acssynbio.9b00415. Epub 2020 Feb 3. ACS Synth Biol. 2020. PMID: 31992039

9

Programmable On-Chip Artificial Cell Producing Post-Translationally Modified Ubiquitinated Protein.

Zilberzwige-Tal S, Levin A, Toprakcioglu Z, Knowles TPJ, Gazit E, Elbaz J. Zilberzwige-Tal S, et al. Among authors: elbaz j. Small. 2019 Aug;15(31):e1901780. doi: 10.1002/smll.201901780. Epub 2019 Jun 17. Small. 2019. PMID: 31207024

10

Cell competition during reprogramming gives rise to dominant clones.

Shakiba N, Fahmy A, Jayakumaran G, McGibbon S, David L, Trcka D, Elbaz J, Puri MC, Nagy A, van der Kooy D, Goyal S, Wrana JL, Zandstra PW. Shakiba N, et al. Among authors: elbaz j. Science. 2019 Apr 26;364(6438):eaan0925. doi: 10.1126/science.aan0925. Epub 2019 Mar 21. Science. 2019. PMID: 30898844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page